Omeros announces agreement to sell omidria® franchise to rayner surgical in a transaction valued in excess of $1 billion

Seattle--(business wire)--omeros corporation (nasdaq: omer) today announced that it has entered into a definitive agreement for the sale of omidria to rayner surgical group limited. expected to close on or before december 31, 2021, the transaction includes an upfront payment of $125 million with an additional $200 million in a commercial milestone payment. omeros will also retain its accounts receivable balance at the closing, which was $34 million at the end of last quarter. together with subs
OMER Ratings Summary
OMER Quant Ranking